Post Reply
2381-2400 of 10899
Or it might roar up again like last month..this is a stressful share and we get caught unaware...either up or down..people suffer.
stocksburntme ( Date: 26-Apr-2012 13:14) Posted:
|
next week they will come out with another lame report. then will cut their forecast again. then selldown again. same old pattern
reposted here..
It says " Even after making downward adjustments to our forecasts, we find that valuations are still attractive and the recent sell-down is overdone. Maintain BUY with SOTP-based target price of SGD1.67."
From Maybank Kim Eng
| Biosensors International - Whither the price of stents (BUY, TP SGD1.67, BIG SP, Healthcare) |
Ø While we think that Biosensors could easily attain its 80% topline growth for FY3/12 as guided, we fear that margins are becoming increasingly vulnerable to ASP pressure where an adverse impact would likely be felt from FY3/13F onwards. Ø Industry sources expect Beijing’s new DES tender process to lead to a 15% price cut. Outside of China however, ASP pressures have moderated. Ø Even after making downward adjustments to our forecasts, we find that valuations are still attractive and the recent sell-down is overdone. Maintain BUY with SOTP-based target price of SGD1.67. |
| YEAK Chee Keong, CFAyeakcheekeong@maybank-ke.com.sg(65) 6433 5730 |
Sorry newbie here. What is BBs and Kateks?
any lame news will just give BB a chance to shot further.
Hey Veteran, I saw that KE Research report but did not find it alarming and cannot believe it's causing today's fall to 1.35.
Hey Wanger, I am tempted to follow this stock down and get another 10 lots. I started buying at 1.50.
Do you know why this stock is falling?
Biosensors: stock is down 1.4% at $1.37, extending losses for the 6th consecutive day. KE Research highlighted yday that there is growing concern over ASP trends for drug eluting stents (DES), which is Biosensors' key pdt. Industry sources expect Beijing's new DES tender process to lead to a 15% px cut, which could erode Biosensors' margins. China is estimated to account for 30% of Biosensors' total revenue. The house lowered TP to $1.82 from $1.67, though it kept its Buy rating.
buy when theres fear...
yiming2000 ( Date: 26-Apr-2012 11:50) Posted:
|
You tell me, buddy. It's falling like a rock.
Our BB friend are the culprit. When all feeling depress its time for them to cope cheap stocks, i've seen it many many time, I'll playing along with them now.
sylvincent ( Date: 26-Apr-2012 11:45) Posted:
|
Why it keeps dropping when the financials are expected to be good?
Be patience. Will scoop up when the selling is over. Still have not find its bottom. Tan tan tan. 
stocksburntme ( Date: 26-Apr-2012 11:07) Posted:
|
Tunami is sweeping this counter when all feel depress, BB will cope it at lower price .... The more lower its goes the more profitable this counter look when the report is out... 234% profit verse 44% last yr.... Woah.
this is one hopeless counter
bleeding nonstop....die pain pain
found its floor?? may the trustworthy 200ma save the day?
looks oversold and over due for a rebound...but rebound has its limits...
infancybird ( Date: 25-Apr-2012 13:37) Posted:
|
BB is still suppressing the price close to $1.40. No end is seen yet. We just have to wait patiently for the revelation of truth.
sinisteral ( Date: 25-Apr-2012 12:09) Posted:
|
Not much of movement. Still kept in the low 1.4s.
Agreed that this is truly a 'heart attack' counter!
When it goes up- it goes up fiercely...when it goes down- it also goes down fiercely..think we need stents soon for our heart attacks.
bishan22 ( Date: 25-Apr-2012 09:42) Posted:
|